FGFR2-BICC1: A Subtype Of FGFR2 Oncogenic Fusion Variant In Cholangiocarcinoma And The Response To Sorafenib

Fibroblast growth factor receptor (FGFR) family includes four highly conserved receptor tyrosine kinases. Particularly, FGFR2 has been identified as a potential target for tyrosine kinase inhibitor (TKI) treatment. Except for immunohistochemistry and fluorescence in situ hybridization, next-generati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ying, Xihui, Tu, Jianfei, Wang, Wenxian, Li, Xingliang, Xu, Chunwei, Ji, Jiansong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842751/
https://www.ncbi.nlm.nih.gov/pubmed/31807010
http://dx.doi.org/10.2147/OTT.S218796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6842751/
https://www.ncbi.nlm.nih.gov/pubmed/31807010
http://dx.doi.org/10.2147/OTT.S218796

Ejemplares similares